Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HEASLEY, MEGHAN CHRISTINE | 1 | 76.5% | +35.6% |
| OUSPENSKI, ILIA I | 1 | 77.6% | +20.3% |
| ALSOMAIRY, SARAH ABDOALATIF | 1 | 60.1% | +25.4% |
| NATARAJAN, MEERA | 1 | 62.2% | +16.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18272826 | GARP Protein Antibody and Use Thereof | NATARAJAN, MEERA | 31d overdue |
| 18278388 | PREPARATION OF SIGLEC-15 BINDING PROTEIN AND USE THEREOF | OUSPENSKI, ILIA I | 22d overdue |
| 18552784 | PREPARATION METHOD FOR BICYCLIC COMPOUND AND APPLICATION AS ANTIFUNGAL AGENT | HEASLEY, MEGHAN CHRISTINE | 17d overdue |
| 18264819 | ANTI-PD-L1 ANTIBODY AND USE THEREOF | ALSOMAIRY, SARAH ABDOALATIF | 33d |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1644 | 1 |
| 1646 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18552784 | PREPARATION METHOD FOR BICYCLIC COMPOUND AND APPLICATION AS ANTIFUNGAL AGENT | HEASLEY, MEGHAN CHRISTINE | 1626 | §112 | Non-Final OA | 17d overdue | Pending | Sep 27, 2023 |
| 18278388 | PREPARATION OF SIGLEC-15 BINDING PROTEIN AND USE THEREOF | OUSPENSKI, ILIA I | 1644 | §112 | Non-Final OA | 22d overdue | Pending | Aug 22, 2023 |
| 18264819 | ANTI-PD-L1 ANTIBODY AND USE THEREOF | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §112 | Non-Final OA | 33d | Pending | Aug 09, 2023 |
| 18272826 | GARP Protein Antibody and Use Thereof | NATARAJAN, MEERA | 1643 | §112 | Non-Final OA | 31d overdue | Pending | Jul 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial